Gilead Sciences' spending on research and development 2008-2022

Published by
Matej Mikulic,
Mar 21, 2023
Gilead Sciences spent some five billion U.S. dollars on research and development in 2022. The statistic illustrates Gilead Sciences' spending on research and development from 2008 to 2022. In 2022, Gilead Sciences shot to the public limelight over its drug remdesivir (brand name Veklury), which was trialed and later approved as a drug against COVID-19.

Gilead Sciences' spending on research and development from 2008 to 2022 (in million U.S. dollars)

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

February 2023

Region

Worldwide

Survey time period

2008 to 2022

Supplementary notes

Figures for 2008-2019 were added from previous annual reports.
* Restated.

Open this statistic in...
Spanish
Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$189 USD $149 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

10

Other regions

9

Related statistics

10

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Biotechnology industry in Germany Global pharmaceutical industryBiotech drugs
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Menu